Sign in
HCM Stock Price, Chart, Stats & News
HUTCHMED (China) Limited
Save
HUTCHMED (China) Limited (HCM) does not currently pay a dividend.
1.56B
Market cap
4.43x
Current P/E
14.66x
Forward P/E
HCM chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
HUTCHMED (China) Limited is a biopharmaceutical company engaged in the research, development, and commercialization of innovative targeted therapies and immunotherapies. Its focus lies in treating cancer and immunological disorders, serving patients both in Hong Kong and globally. The company's operations are divided into Oncology/Immunology and Other Ventures.
Similar securities
Based on sector and market capitalization
Report issue